Symptoms of Attenuated Psychosis Syndrome in Relatives of Clinical High-Risk Youth: Preliminary Evidence

被引:0
|
作者
Tarbox-Berry, Sarah, I [1 ,2 ,4 ]
Walsh, Barbara C. [1 ]
Pogue-Geile, Michael F. [3 ]
Woods, Scott W. [1 ]
机构
[1] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA
[2] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI USA
[3] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA USA
[4] Univ Hlth Ctr, 8C 14,4201 St Antoine St, Detroit, MI 48201 USA
关键词
prodrome; psychosis; APS; CHR; family study; ULTRA-HIGH RISK; PRODROMAL SYMPTOMS; INTERRATER RELIABILITY; STRUCTURED INTERVIEW; INDIVIDUALS; SCHIZOPHRENIA; SCALE; PREDICTORS; PERFORMANCE; VALIDITY;
D O I
10.1093/schbul/sbad001
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background and Hypothesis Attenuated Psychosis Syndrome (APS) impacts functioning and predicts increased risk of psychosis. Risk for developing APS itself has received minimal attention. Knowledge of familial and environmental contributions to APS symptoms would advance understanding of APS and risk for psychosis. As an initial step, this report presents the first data on APS symptoms in family members of APS patients. Study Design This study utilized a discordant sibling-pair family study design. The Structured Interview for Psychosis-risk Syndromes (SIPS) was administered to 17 APS probands and 26 non-APS biological siblings. Probands and siblings were compared on positive, negative, disorganized, and general SIPS symptom scales and factors derived from those scales. Study Results There was significantly greater symptom severity in probands compared to siblings on nine of 19 SIPS scales. Negative/anxiety, functioning, and positive symptom factors were identified. Probands showed significantly greater severity than siblings on the negative/anxiety and positive factors. Elevated pathology on the negative/anxiety factor best differentiated between probands and siblings, over and above the contribution of the positive factor. No difference was found for the functioning factor. Conclusions Results support the importance of non-familial effects on risk for APS and suggest differences in familial contribution to APS symptoms. Understanding the relative contribution of familial and environmental effects on APS symptoms may reveal important differences among APS patients, with implications for risk characterization, symptom course, and treatment selection.
引用
收藏
页码:1022 / 1031
页数:10
相关论文
共 50 条
  • [31] SELF-ESTEEM AND SYMPTOMS IN INDIVIDUALS AT CLINICAL HIGH-RISK FOR PSYCHOSIS
    Benavides, Caridad
    Brucato, Gary
    Kimhy, David
    SCHIZOPHRENIA BULLETIN, 2018, 44 : S233 - S233
  • [32] Stigma related to labels and symptoms in individuals at clinical high-risk for psychosis
    Yang, Lawrence H.
    Link, Bruce G.
    Ben-David, Shelly
    Gill, Kelly E.
    Girgis, Ragy R.
    Brucato, Gary
    Wonpat-Borja, Ahtoy J.
    Corcoran, Cheryl M.
    SCHIZOPHRENIA RESEARCH, 2015, 168 (1-2) : 9 - 15
  • [33] Early prodromal symptoms can predict future psychosis in familial high-risk youth
    Tandon, Neeraj
    Montrose, Debra
    Shah, Jai
    Rajarethinam, R. P.
    Diwadkar, Vaibhav A.
    Keshavan, Matcheri S.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2012, 46 (01) : 105 - 110
  • [34] Relatives' expressed emotion, distress and attributions in clinical high-risk and recent onset of psychosis
    Dominguez-Martinez, Tecelli
    Medina-Pradas, Cristina
    Kwapil, Thomas R.
    Barrantes-Vidal, Neus
    PSYCHIATRY RESEARCH, 2017, 247 : 323 - 329
  • [35] The development of the Content of Attenuated Positive Symptoms Codebook for those at clinical high risk of psychosis
    Marshall, Catherine
    Falukozi, Erin
    Albertin, Monica
    Zhu, Haifeng
    Addington, Jean
    PSYCHOSIS-PSYCHOLOGICAL SOCIAL AND INTEGRATIVE APPROACHES, 2012, 4 (03): : 191 - 202
  • [36] LONGITUDINAL ASSOCIATION OF STRESS MEASURES WITH SYMPTOMS IN YOUTH AT CLINICAL HIGH RISK FOR PSYCHOSIS
    DeVylder, Jordan E.
    Ben-David, Shelly
    Schobel, Scott
    Kimhy, David
    Corcoran, Cheryl M.
    SCHIZOPHRENIA RESEARCH, 2012, 136 : S215 - S215
  • [37] Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study
    Devoe, D. J.
    Lu, L.
    Cannon, T. D.
    Cadenhead, K. S.
    Cornblatt, B. A.
    McGlashan, T. H.
    Perkins, D. O.
    Seidman, L. J.
    Tsuang, M. T.
    Woods, S. W.
    Walker, E. F.
    Mathalon, D. H.
    Bearden, C. E.
    Addington, J.
    SCHIZOPHRENIA RESEARCH, 2021, 227 : 28 - 37
  • [38] INDIVIDUALIZED PREDICTION MODELS FOR PSYCHOSIS AND RELATED OUTCOMES IN YOUTH AT CLINICAL HIGH-RISK
    Cannon, Tyrone
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2023, 62 (10): : S147 - S147
  • [39] The support, treatment, and resilience (STAR) program for youth at clinical high-risk of psychosis
    Millman, Zachary B.
    Guvenek-Cokol, P. Esra
    Kim, Hyun Jung
    Ongur, Dost
    Carol, Emily E.
    SCHIZOPHRENIA RESEARCH, 2022, 248 : 122 - 123
  • [40] Motor sequence learning and pattern recognition in youth at clinical high-risk for psychosis
    Damme, Katherine S. F.
    Gallagher, Natalie
    Vargas, Teresa
    Osborne, K. Juston
    Gupta, Tina
    Mittal, Vijay A.
    SCHIZOPHRENIA RESEARCH, 2019, 208 : 454 - 456